TradingView
Camslam22
Apr 25, 2022 5:15 PM

ATER Pharma Long

NASDAQ:ATER1D
Aterian, Inc.NASDAQ

Description

⋅
ATER has traded down to a support level and 0.62 Fib retracement. ATER has an upcoming pharmaceutical approval from the FDA for one of their drugs which remains in stage 2 trials.
Trend AnalysisChart PatternsHarmonic PatternsATERPHARMAlongscalls
Comments
FloridaManFinance
⋅
Umm what exactly are you talking about regarding ATER and an FDA approval ... ?
More